The Lan et al. paper emphasises the established role of GREMLIN as a key determinant of epithelial and stem-like phenotypes in various human tumours and suggests the usefulness of agonistic GREMLIN-like biologicals that could possibly mediate differentiation therapy in human tumours, including PDAC. This evidence concerns the gene GREM1 and neoplasm.